SE9802729D0 - Novel Compounds - Google Patents
Novel CompoundsInfo
- Publication number
- SE9802729D0 SE9802729D0 SE9802729A SE9802729A SE9802729D0 SE 9802729 D0 SE9802729 D0 SE 9802729D0 SE 9802729 A SE9802729 A SE 9802729A SE 9802729 A SE9802729 A SE 9802729A SE 9802729 D0 SE9802729 D0 SE 9802729D0
- Authority
- SE
- Sweden
- Prior art keywords
- novel compounds
- therapy
- processes
- preparation
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9802729A SE9802729D0 (sv) | 1998-08-13 | 1998-08-13 | Novel Compounds |
ES99943554T ES2190246T3 (es) | 1998-08-13 | 1999-08-03 | Nuevos compuestos de tiazolopirimidina. |
AU56625/99A AU768004B2 (en) | 1998-08-13 | 1999-08-03 | Novel thiazolopyrimidine compounds |
DE69905170T DE69905170T2 (de) | 1998-08-13 | 1999-08-03 | Thiazolopyrimidinderivate |
US09/403,392 US6806273B1 (en) | 1998-08-13 | 1999-08-03 | Compounds |
AT99943554T ATE231872T1 (de) | 1998-08-13 | 1999-08-03 | Thiazolopyrimidinderivate |
CA002338600A CA2338600C (en) | 1998-08-13 | 1999-08-03 | Novel thiazolopyrimidine compounds |
NZ509457A NZ509457A (en) | 1998-08-13 | 1999-08-03 | Thiazolopyrimidine compounds suitable for the treatment of inflammatory disorders |
PCT/SE1999/001333 WO2000009511A1 (en) | 1998-08-13 | 1999-08-03 | Novel thiazolopyrimidine compounds |
EP99943554A EP1104425B1 (en) | 1998-08-13 | 1999-08-03 | Novel thiazolopyrimidine compounds |
DK99943554T DK1104425T3 (da) | 1998-08-13 | 1999-08-03 | Hidtil ukendte thiazolopyrimidinforbindelser |
JP2000564962A JP4612189B2 (ja) | 1998-08-13 | 1999-08-03 | 新規チアゾロピリミジン化合物 |
JP2010110322A JP2010168405A (ja) | 1998-08-13 | 2010-05-12 | 新規チアゾロピリミジン化合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9802729A SE9802729D0 (sv) | 1998-08-13 | 1998-08-13 | Novel Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9802729D0 true SE9802729D0 (sv) | 1998-08-13 |
Family
ID=20412248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9802729A SE9802729D0 (sv) | 1998-08-13 | 1998-08-13 | Novel Compounds |
Country Status (12)
Country | Link |
---|---|
US (1) | US6806273B1 (sv) |
EP (1) | EP1104425B1 (sv) |
JP (2) | JP4612189B2 (sv) |
AT (1) | ATE231872T1 (sv) |
AU (1) | AU768004B2 (sv) |
CA (1) | CA2338600C (sv) |
DE (1) | DE69905170T2 (sv) |
DK (1) | DK1104425T3 (sv) |
ES (1) | ES2190246T3 (sv) |
NZ (1) | NZ509457A (sv) |
SE (1) | SE9802729D0 (sv) |
WO (1) | WO2000009511A1 (sv) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9903544D0 (sv) | 1999-10-01 | 1999-10-01 | Astra Pharma Prod | Novel compounds |
JP2003522191A (ja) * | 2000-02-11 | 2003-07-22 | アストラゼネカ・アクチエボラーグ | ケモカイン受容体活性のモジュレーターとしてのピリミジン化合物およびそれらの使用 |
GB2359081A (en) * | 2000-02-11 | 2001-08-15 | Astrazeneca Uk Ltd | Pharmaceutically active thiazolopyrimidines |
GB2359078A (en) | 2000-02-11 | 2001-08-15 | Astrazeneca Uk Ltd | Pharmaceutically active pyrimidine derivatives |
GB2359551A (en) | 2000-02-23 | 2001-08-29 | Astrazeneca Uk Ltd | Pharmaceutically active pyrimidine derivatives |
CZ2003132A3 (cs) * | 2000-07-18 | 2003-09-17 | Smithkline Beecham Corporation | Farmaceutický prostředek pro léčení příznaků běžného nachlazení |
SE0003828D0 (sv) | 2000-10-20 | 2000-10-20 | Astrazeneca Ab | Novel compounds |
SE0101082D0 (sv) * | 2001-03-27 | 2001-03-27 | Astrazeneca Ab | Novel use |
SE0101322D0 (sv) | 2001-04-12 | 2001-04-12 | Astrazeneca Ab | Novel compounds |
SE0102716D0 (sv) * | 2001-08-14 | 2001-08-14 | Astrazeneca Ab | Novel compounds |
GB0217431D0 (en) * | 2002-07-27 | 2002-09-04 | Astrazeneca Ab | Novel compounds |
ATE323702T1 (de) | 2002-08-06 | 2006-05-15 | Astrazeneca Ab | Kondensierte pyridine und pyrimidine mit tie2 (tek) aktivität |
DE60318219T2 (de) * | 2002-08-24 | 2009-01-15 | Astrazeneca Ab | PYRIMIDINDERIVATE ALS MODULATOREN DER AKTIVITuT VON CHEMOKINREZEPTOREN |
GB0221828D0 (en) | 2002-09-20 | 2002-10-30 | Astrazeneca Ab | Novel compound |
GB0221829D0 (en) * | 2002-09-20 | 2002-10-30 | Astrazeneca Ab | Novel compound |
WO2005033115A1 (en) * | 2003-10-07 | 2005-04-14 | Astrazeneca Ab | New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1 |
GB0328243D0 (en) | 2003-12-05 | 2004-01-07 | Astrazeneca Ab | Methods |
DK1809624T3 (da) | 2004-08-28 | 2014-01-20 | Astrazeneca Ab | Pyrimidinsulfonamidderivater som kemokinreceptor-modulatorer |
WO2006046739A1 (ja) | 2004-10-29 | 2006-05-04 | Eisai R & D Management Co., Ltd. | 炎症性疾患治療剤 |
EP1844054A2 (en) * | 2004-12-17 | 2007-10-17 | AstraZeneca AB | Thiazolopyrimidine compounds for the modulation of chemokine receptor activity |
UA90707C2 (en) | 2005-04-06 | 2010-05-25 | Астразенека Аб | Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives |
AR053347A1 (es) | 2005-04-06 | 2007-05-02 | Astrazeneca Ab | Derivados de [1,3]tiazolo[4,5-d]pirimidin-2(3h)-ona 5,7-sustituidos |
TW200820973A (en) | 2006-09-29 | 2008-05-16 | Astrazeneca Ab | Novel compounds 480 |
WO2008039139A1 (en) | 2006-09-29 | 2008-04-03 | Astrazeneca Ab | Novel 5,7-disubstituted [1, 3] thiazolo [4, 5] pyrimidin-2 (3h)-amine derivatives and their use in therapy |
WO2008094662A2 (en) | 2007-02-01 | 2008-08-07 | Interdigital Technology Corporation | Method and apparatus for supporting rlc re-segmentation |
BRPI0908529A2 (pt) * | 2008-02-26 | 2015-09-29 | Novartis Ag | composto orgânicos |
US20120122819A1 (en) | 2009-06-12 | 2012-05-17 | Socpra - Sciences Et Genie S.E.C. | Guanine riboswitch binding compounds and their use as antibiotics |
JO3437B1 (ar) | 2009-10-30 | 2019-10-20 | Esai R & D Man Co Ltd | أجسام مضادة محسنة مضادة للفراكتالكين البشري واستخداماتها |
CN106279211B (zh) * | 2015-06-03 | 2020-09-15 | 北京大学 | 一种噻唑并嘧啶酮化合物及其制备方法和应用 |
GB201807898D0 (en) | 2018-05-15 | 2018-06-27 | Kancera Ab | New processes and products with increased chiral purity |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB713652A (en) * | 1951-06-04 | 1954-08-18 | Wellcome Found | Improvements in or relating to heterocyclic compounds and their manufacture |
BE543978A (sv) | 1955-01-03 | |||
US5202328A (en) * | 1991-03-06 | 1993-04-13 | Merck & Co., Inc. | Substituted fused pyrimidinones |
WO1999051608A1 (en) * | 1998-04-03 | 1999-10-14 | Du Pont Pharmaceuticals Company | THIAZOLO[4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS |
-
1998
- 1998-08-13 SE SE9802729A patent/SE9802729D0/sv unknown
-
1999
- 1999-08-03 CA CA002338600A patent/CA2338600C/en not_active Expired - Fee Related
- 1999-08-03 NZ NZ509457A patent/NZ509457A/xx not_active IP Right Cessation
- 1999-08-03 EP EP99943554A patent/EP1104425B1/en not_active Expired - Lifetime
- 1999-08-03 AT AT99943554T patent/ATE231872T1/de active
- 1999-08-03 JP JP2000564962A patent/JP4612189B2/ja not_active Expired - Fee Related
- 1999-08-03 DK DK99943554T patent/DK1104425T3/da active
- 1999-08-03 US US09/403,392 patent/US6806273B1/en not_active Expired - Fee Related
- 1999-08-03 DE DE69905170T patent/DE69905170T2/de not_active Expired - Lifetime
- 1999-08-03 AU AU56625/99A patent/AU768004B2/en not_active Ceased
- 1999-08-03 WO PCT/SE1999/001333 patent/WO2000009511A1/en active IP Right Grant
- 1999-08-03 ES ES99943554T patent/ES2190246T3/es not_active Expired - Lifetime
-
2010
- 2010-05-12 JP JP2010110322A patent/JP2010168405A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
NZ509457A (en) | 2002-07-26 |
AU768004B2 (en) | 2003-11-27 |
EP1104425A1 (en) | 2001-06-06 |
ATE231872T1 (de) | 2003-02-15 |
CA2338600A1 (en) | 2000-02-24 |
US6806273B1 (en) | 2004-10-19 |
DK1104425T3 (da) | 2003-06-23 |
JP4612189B2 (ja) | 2011-01-12 |
ES2190246T3 (es) | 2003-07-16 |
EP1104425B1 (en) | 2003-01-29 |
CA2338600C (en) | 2008-01-08 |
JP2010168405A (ja) | 2010-08-05 |
DE69905170D1 (en) | 2003-03-06 |
DE69905170T2 (de) | 2004-01-15 |
AU5662599A (en) | 2000-03-06 |
WO2000009511A1 (en) | 2000-02-24 |
JP2002522544A (ja) | 2002-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9802729D0 (sv) | Novel Compounds | |
SE9704546D0 (sv) | Novel compounds | |
CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
ES2184149T3 (es) | Paclitaxeles 6-tio sustituidos. | |
TR200100054T2 (tr) | Paroksetin metansülfonat | |
SE9704544D0 (sv) | Novel compounds | |
TR200001203T2 (tr) | Yeni birleşik maddeler | |
TR200001218T2 (tr) | İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler. | |
DK0760848T3 (da) | Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf | |
ID23374A (id) | Halogenopirimidin | |
GB0004128D0 (en) | Novel compounds | |
TW200505875A (en) | Novel compounds | |
TR200000152T2 (tr) | Yeni bileşikler. | |
YU13301A (sh) | Muskarinski agonisti i antagonisti | |
SE9802937D0 (sv) | Novel compounds | |
SE9904377D0 (sv) | Pharmaceutical combinations | |
SE0102716D0 (sv) | Novel compounds | |
SE9801494D0 (sv) | Novel use | |
MY127474A (en) | Naphthyl compounds, intermediates, compositions, and methods of use | |
ATE28188T1 (de) | Antikonvulsive mittel. | |
BR9802803A (pt) | ação e composições farmacêuticas contendo os mesmos. | |
NO20005548L (no) | Mykobakterieinhibitorer | |
NZ217356A (en) | Benzamide derivatives and pharmaceutical compositions | |
ATE250340T1 (de) | 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele | |
NO20021429D0 (no) | 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner |